{"id":"F2007B01082","name":"National Health Act 1953 - Declaration under subsection 85(2AA) (No. PB 9 of 1992)","slug":"national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-9-of-1992","collection":"legislative_instrument","jurisdiction":"commonwealth","status":"repealed","isInForce":false,"actNumber":null,"makingDate":null,"administeringDepartment":null,"currentVersion":{"id":62622,"registerId":"commonwealth-F2007B01082-current","compilationNumber":null,"startDate":"2026-04-02","status":"Repealed","reasons":null,"registeredAt":null},"sections":[{"sectionNumber":"1","sectionType":"section","heading":"National Health Act 1953 - Declaration under subsection 85(2AA) (No. PB 9 of 1992)","content":"COMMONWEALTH OF AUSTRALIA\n\nNational Health Act 1953\n\nPHARMACEUTICAL BENEFITS\n\nDECLARATION UNDER SUBSECTION 85 (2AA)\n\nNo. PB 9 of 1992\n\nI, DENISE MARY SWIFT, Acting Assistant Secretary, Pharmaceutical Benefits Branch, Department of Health, Housing and Community Services and Delegate of the Minister of State for Health, Housing and Community Services, having in accordance with subsection 85 (2AB) of the National Health Act 1953 obtained the advice of the Pharmaceutical Benefits Advisory Committee, pursuant to subsection 85 (2AA) of the National Health Act 1953, hereby make the following Declaration:\n\n1. This Declaration shall come into operation on 1 August 1992.\n\n2. The drug calcium glubionate shall cease to be a drug to which Part VII of the National Health Act 1953 applies.\n\nDated this fourteenth day of July 1992.\n\nDENISE SWIFT\n\nActing Assistant Secretary\n\nPharmaceutical Benefits Branch\n\nDepartment of Health, Housing and Community Services\n\nDelegate of the Minister of State for Health, Housing and Community Services","sortOrder":0}],"analysis":{"kimi_summary":{"_metrics":{"model":"kimi-k2.5","source":"moonshot-batch","completionTokens":2099},"content_quality":"ok","complexity_score":1,"scope_assessment":{"changed":false,"description":"This declaration performs its narrow, intended administrative function of modifying the Pharmaceutical Benefits Scheme by removing a specific drug. It has not expanded beyond its original purpose."},"complexity_factors":["Only 2 operative paragraphs","Single substantive action (removing one named drug)","No defined terms section","No conditional logic or exceptions","Minimal cross-referencing (only to parent Act sections)"],"plain_english_summary":"This declaration removed the calcium glubionate listing from Australia’s Pharmaceutical Benefits Scheme effective 1 August 1992. From that date patients needing this calcium supplement would no longer receive the PBS subsidy and would face full private prices at pharmacies.\n\nThe change was made by a senior Health Department official acting for the Minister, following advice from the Pharmaceutical Benefits Advisory Committee — typically reflecting reassessment of cost‑effectiveness, alternatives, or changed need for subsidisation."}},"importantCases":[],"_links":{"self":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-9-of-1992","history":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-9-of-1992/history","analysis":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-9-of-1992/analysis","conflicts":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-9-of-1992/conflicts","importantCases":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-9-of-1992/important-cases","documents":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-9-of-1992/documents"}}